Cardiovascular disease in formerly preeclamptic wome

Completed

• Conditions: hypertensive disorders of pregnancy; Toxemia; 10026906; 10057166

• Registration Number: NL-OMON33561
• Lead Sponsor: Academisch Ziekenhuis Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

Inclusion of women who participated in a previous clinical study in the period of 1996-1999. Women with preeclampsia or HELLP syndrome in history and controls with a history of uncomplicated pregnancy.

Exclusion Criteria

Preexistent hypertension (before pregnancy)

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Renal vascular resistance</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Glomerular filtration rate (GFR), total peripheral vascular resistance (TPVR),<br /><br>blood pressure, plasma volume, arterial and venous compliance and<br /><br>cardiovascular morbidity. </p><br>